146 related articles for article (PubMed ID: 29699605)
1. Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity.
Kim DH; Choi JM
BMB Rep; 2018 May; 51(5):207-208. PubMed ID: 29699605
[TBL] [Abstract][Full Text] [Related]
2. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
[TBL] [Abstract][Full Text] [Related]
3. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
[TBL] [Abstract][Full Text] [Related]
4. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.
Salembier R; De Haes C; Bellemans J; Demeyere K; Van Den Broeck W; Sanders NN; Van Laere S; Lyons TR; Meyer E; Steenbrugge J
Breast Cancer Res; 2024 Apr; 26(1):63. PubMed ID: 38605414
[TBL] [Abstract][Full Text] [Related]
5. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
[No Abstract] [Full Text] [Related]
6. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
[TBL] [Abstract][Full Text] [Related]
7. The critical role of type-1 innate and acquired immunity in tumor immunotherapy.
Ikeda H; Chamoto K; Tsuji T; Suzuki Y; Wakita D; Takeshima T; Nishimura T
Cancer Sci; 2004 Sep; 95(9):697-703. PubMed ID: 15471553
[TBL] [Abstract][Full Text] [Related]
8. Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.
Eurich K; Segawa M; Toei-Shimizu S; Mizoguchi E
World J Gastroenterol; 2009 Nov; 15(42):5249-59. PubMed ID: 19908331
[TBL] [Abstract][Full Text] [Related]
9. RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis.
Ma B; Herzog EL; Moore M; Lee CM; Na SH; Lee CG; Elias JA
Sci Rep; 2016 May; 6():26299. PubMed ID: 27198666
[TBL] [Abstract][Full Text] [Related]
10. The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation.
Görgens SW; Hjorth M; Eckardt K; Wichert S; Norheim F; Holen T; Lee S; Langleite T; Birkeland KI; Stadheim HK; Kolnes KJ; Tangen DS; Kolnes AJ; Jensen J; Drevon CA; Eckel J
Acta Physiol (Oxf); 2016 Mar; 216(3):330-45. PubMed ID: 26303257
[TBL] [Abstract][Full Text] [Related]
11. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases.
Yeo IJ; Lee CK; Han SB; Yun J; Hong JT
Pharmacol Ther; 2019 Nov; 203():107394. PubMed ID: 31356910
[TBL] [Abstract][Full Text] [Related]
12. CHI3L1 enhances melanoma lung metastasis
Ma B; Kamle S; Akosman B; Khan H; Lee CM; Lee CG; Elias JA
Front Immunol; 2022; 13():1056397. PubMed ID: 36618349
[TBL] [Abstract][Full Text] [Related]
13. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
Libreros S; Garcia-Areas R; Shibata Y; Carrio R; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Cancer; 2012 Jul; 131(2):377-86. PubMed ID: 21866546
[TBL] [Abstract][Full Text] [Related]
14. Recently Updated Role of Chitinase 3-like 1 on Various Cell Types as a Major Influencer of Chronic Inflammation.
Mizoguchi E; Sadanaga T; Nanni L; Wang S; Mizoguchi A
Cells; 2024 Apr; 13(8):. PubMed ID: 38667293
[TBL] [Abstract][Full Text] [Related]
15. Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.
Ma B; Herzog EL; Lee CG; Peng X; Lee CM; Chen X; Rockwell S; Koo JS; Kluger H; Herbst RS; Sznol M; Elias JA
Cancer Res; 2015 Feb; 75(3):487-96. PubMed ID: 25511377
[TBL] [Abstract][Full Text] [Related]
16. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
[TBL] [Abstract][Full Text] [Related]
17. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.
Cohen N; Shani O; Raz Y; Sharon Y; Hoffman D; Abramovitz L; Erez N
Oncogene; 2017 Aug; 36(31):4457-4468. PubMed ID: 28368410
[TBL] [Abstract][Full Text] [Related]
18. Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells.
Li Z; Lu H; Gu J; Liu J; Zhu Q; Lu Y; Wang X
Inflammation; 2017 Oct; 40(5):1576-1588. PubMed ID: 28656528
[TBL] [Abstract][Full Text] [Related]
19. Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9.
Low D; Subramaniam R; Lin L; Aomatsu T; Mizoguchi A; Ng A; DeGruttola AK; Lee CG; Elias JA; Andoh A; Mino-Kenudson M; Mizoguchi E
Oncotarget; 2015 Nov; 6(34):36535-50. PubMed ID: 26431492
[TBL] [Abstract][Full Text] [Related]
20. CHI3L1 alleviate acute liver injury by inhibiting Th1 cells differentiation through STAT3 signaling pathway.
Zhang S; Dai X; Shi Y; Zhu X; Dai Y; Qian X; Gu J
Ann Transl Med; 2021 Apr; 9(7):529. PubMed ID: 33987227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
